Floatz logo

DEXAMETHASONE

Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma

Ohio State University Comprehensive Cancer CenterSmall moleculePhase 2Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
National Cancer Institute (NCI)
Phase 2B
Cyclophosphamide
National Cancer Institute (NCI)
Phase 2B
FILGRASTIM
National Cancer Institute (NCI)
Phase 2B
Vinorelbine
National Cancer Institute (NCI)
Phase 2B
Ifosfamide
National Cancer Institute (NCI)
Phase 2B

View all 16 →

Same molecule, other indications

DEXAMETHASONE is also rated in:

chemotherapy-induced toxicityDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →